S
Susanne Schaffert
Head of Northern and Central Europe, Oncology, Novartis
IN HER JURISDICTION: 27 countries, 400 employees, travels half the time ... and still average seven hours of sleep a night
You're a nice chemistry PhD, but you don't know the business,'" Susanne Schaffert was told when she joined Novartis in 1997—and was promptly sent into the field. "It was tough, but a great learning experience." Being pushed out of her comfort zone is something the 41-year-old Germany native welcomes because it challenges her to be creative and adaptable.
Susanne Schaffert
An "aha!" moment struck when she was global brand manager in Basel. "I understood how headquarters has to think about the big picture," she says. "From there, it went very fast." Now she leads an $800 million regional oncology franchise. But Schaffert isn't much impressed by big numbers. "I select carefully where I want to be, and don't look too much at how high I am in the hierarchy," she says. Oncology may be the most complex, competitive category, but for Schaffert it's also about "what topics I want to address, what challenges I'm looking for, what I enjoy." The fact that half of the members of the executive board of Novartis Oncology are women was a spur to achievement. "That encouraged me to go further, to take risks," she says.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.